Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background

BMC Public Health. 2017 Nov 25;17(1):904. doi: 10.1186/s12889-017-4923-2.

Abstract

Background: In Germany, over-the-counter (OTC) drugs are normally reimbursed up to the age of 12 years only. The aim of this study was to analyse prices of over-the-counter drugs used by adolescents in Germany and their association with socioeconomic factors.

Methods: Based on the German GINIplus and LISAplus birth cohorts, data on drug utilization among 15-year-old adolescents (n = 4677) were collected using a self-administered questionnaire. The reported drugs were subdivided into prescription drugs and OTC drugs. The drugs' prices were tracked by the pharmaceutical identification numbers.

Results: Overall, 1499 OTC drugs with clearly identifiable prices were eligible for analysis. Their mean price was €9.75 (95% confidence interval: €9.27-10.22). About 75% of the OTC drugs cost less than €10. Higher mean prices were associated with residing in Munich (€10.74; 95% confidence interval: €9.97-11.52) and with higher paternal education (e.g. highest education level: €10.17; 95% confidence interval: €9.47-10.86). Adolescents residing in Munich (in comparison with the less wealthy region of Wesel) and adolescents with higher educated fathers were also significantly more likely to use OTC drugs costing ≥ €10 or ≥ €25, respectively.

Conclusions: The price of €10 for non-reimbursable OTC drugs may represent a (psychological) threshold. Higher prices could discourage especially adolescents from a lower socioeconomic background from taking medically advisable but non-reimbursable OTC drugs.

Keywords: Adolescent; Drug prices; Drug utilization; Over-the-counter drugs; Socioeconomic factors.

MeSH terms

  • Adolescent
  • Cohort Studies
  • Commerce / statistics & numerical data*
  • Female
  • Germany
  • Humans
  • Insurance, Health, Reimbursement / statistics & numerical data
  • Male
  • Nonprescription Drugs / economics*
  • Nonprescription Drugs / therapeutic use*
  • Prescription Drugs / therapeutic use
  • Socioeconomic Factors
  • Surveys and Questionnaires

Substances

  • Nonprescription Drugs
  • Prescription Drugs